[Form 4] MYOMO, INC. Insider Trading Activity

Rhea-AI Filing Summary

Myomo, Inc. director reports open-market share purchases on a Form 4. The reporting person bought 4,000 shares of Myomo common stock on 11/18/2025 at a price of $0.7345 per share in a single open-market transaction. On 11/19/2025, an additional 385 shares were purchased at a weighted average price of $0.765 per share. Following these transactions, the reporting person beneficially owned 75,748 shares directly and 479 shares indirectly through an immediate family member, for which beneficial ownership is disclaimed except to the extent of any pecuniary interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Crowley Thomas Aloysius Jr.

(Last) (First) (Middle)

C/O MYOMO, INC.

45 BLUE SKY DR., SUITE 101

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MYOMO, INC. [ MYO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		P		4,000(1)	A	$0.7345	75,748	D
Common Stock	11/19/2025		P		385	A	$0.765(2)	479(3)	I	By immediate family memeber of reporting person

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an open market purchase in a single transaction.

2. Represents weighted average purchase price

3. Represents shares held by the Reporting Person's immediate family member. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose.

	/s/ David A. Henry, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Myomo (MYO) disclose in this Form 4 filing?

The filing reports that a director of Myomo, Inc. purchased shares of the company’s common stock in the open market on 11/18/2025 and that an immediate family member purchased additional shares on 11/19/2025.

How many Myomo (MYO) shares did the director purchase?

The director purchased 4,000 shares of Myomo common stock on 11/18/2025 at a price of $0.7345 per share in an open-market transaction.

What additional Myomo (MYO) shares were bought by the director’s family member?

An immediate family member of the reporting person purchased 385 shares of Myomo common stock on 11/19/2025 at a weighted average price of $0.765 per share.

What is the director’s total beneficial ownership in Myomo (MYO) after these transactions?

After the reported transactions, the director beneficially owned 75,748 shares directly and 479 shares indirectly through an immediate family member.

Does the director claim full beneficial ownership of the family member’s Myomo (MYO) shares?

No. The reporting person disclaims beneficial ownership of the 479 shares held by the immediate family member, except to the extent of any pecuniary interest.

Were the Myomo (MYO) share purchases open-market transactions?

Yes. The 4,000-share purchase on 11/18/2025 is described as an open-market purchase in a single transaction, and the 385-share purchase on 11/19/2025 has a reported weighted average purchase price.

Who signed the Myomo (MYO) Form 4?

The Form 4 was signed by /s/ David A. Henry, Attorney-in-Fact on 11/21/2025.